The Role of Inflammatory Mediators in the Pathogenesis of Nonalcoholic Fatty Liver Disease

키워드

참고문헌 (38)

1. Clark JM, "Nonalcoholic fatty liver disease", Gastroenterology, 122, pp.1649~1657 (2002)
2. Ruhl CE, "Epidemiology of nonalcoholic fatty liver", Clin Liver Dis, 8, pp.501~519 (2004)
3. Farrell GC, "Nonalcoholic fatty liver disease: from steatosis to cirrhosis", Hepatology, 43, pp.99~112 (2006)
4. Qureshi K, "Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease", World J Gastroenterol, 13, pp.3540~3553 (2007)
5. Brunt EM, "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
6. McCullough AJ, "Update on nonalcoholic fatty liver disease", J Clin Gastroenterol, 34, pp.255~262 (2002)
7. Day CP, "Steatohepatitis: a tale of two “hits”?", Gastroenterology, 114, pp.842~845 (1998)
8. Sanyal AJ, "Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities", Gastroenterology, 120, pp.1183~1192 (2001)
9. Chitturi S, "Etiopathogenesis of nonalcoholic steatohepatitis", Semin Liver Dis, 21, pp.27~41 (2001)
10. Romeo S, "Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease", Nat Genet, 40, pp.1461~1465 (2008)
11. Santoro N, "A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents", Hepatology, 52, pp.1281~1290 (2010)
12. McCullough AJ, "Pathophysiology of nonalcoholic steatohepatitis", J Clin Gastroenterol, 40, pp.17~29 (2006)
13. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
14. Ahima RS, "Leptin regulation of neuroendocrine systems", Front Neuroendocrinol, 21, pp.263~307 (2000)
15. Wellhoener P, "Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans", J Clin Endocrinol Metab, 85, pp.1267~1271 (2000)
16. Boden G, "Effect of fasting on serum leptin in normal human subjects.", J Clin Endocrinol Metab, 81, pp.3419~3423 (1996)
17. Farooqi IS, "Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine", metabolic dysfunction of human congenital leptin deficiency, 2002, pp.110, 1093~1103
18. Tartaglia LA, "Identification and expression cloning of a leptin receptor, OB-R", Cell, 83, pp.1263~1271 (1995)
19. Corica F, "Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects", Int J Obes Relat Metab Disord, 23, pp.355~360 (1999)
20. Wang Z, "Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling", Biochem Biophys Res Commun, 277, pp.20~26 (2000)
21. Honda H, "Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver", Hepatology, 36, pp.12~21 (2002)
22. Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
23. Hotamisligil GS, "Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance", Science, 271, pp.665~668 (1996)
24. Panagiotakos DB, "The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study", Atherosclerosis, 183, pp.308~315 (2005)
25. Tilg H, "Adipocytokines: mediators linking adipose tissue, inflammation and immunity", Nat Rev Immunol, 6, pp.772~783 (2006)
26. Arita Y, "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity", Biochem Biophys Res Commun, 257, pp.79~83 (1999)
27. Xu A, "The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice", J Clin Invest, 112, pp.91~100 (2003)
28. Papanicolaou DA, "Interleukin-6: the endocrine cytokine", J Clin Endocrinol Metab, 85, pp.1331~1333 (2000)
29. Franckhauser S, "Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice", Diabetologia, 51, pp.1306~1316 (2008)
30. Wieckowska A, "Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis", Am J Gastroenterol, 103, pp.1372~1379 (2008)
31. Rabe K, "Adipokines and insulin resistance", Mol Med, 14, pp.741~751 (2008)
32. Stejskal D, "Resistin-concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease", Biomed Pap Med, 147, pp.63~69 (2003), Fac Univ Palacky Olomouc Czech Repub
33. Silha JV, "Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance", Eur J Endocrinol, 149, pp.331~335 (2003)
34. Singhal NS, "Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice", Am J Physiol Endocrinol Metab, 295, pp.331~338 (2008)
35. Marra F, "Adipokines in liver diseases", Hepatology, 50, pp.957~969 (2009)
36. Dong B, "Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease", Proc Natl Acad Sci USA, 106, pp.18831~18836 (2009)
37. Zheng L, "Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD", J Gastroenterol Hepatol, 25, pp.156~163 (2010)
38. Sato R, "SREBPs: protein interaction and SREBPs", FEBS J, 276, pp.622~627 (2009)

관련 논문AI추천